Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ResMed
RMD
|
+$487M |
| 2 |
Mettler-Toledo International
MTD
|
+$445M |
| 3 |
Copart
CPRT
|
+$409M |
| 4 |
Johnson Controls International
JCI
|
+$364M |
| 5 |
Phillips 66
PSX
|
+$318M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$928M |
| 2 |
Microsoft
MSFT
|
+$910M |
| 3 |
Apple
AAPL
|
+$816M |
| 4 |
Walt Disney
DIS
|
+$687M |
| 5 |
Amazon
AMZN
|
+$484M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.48% |
| 2 | Healthcare | 12.31% |
| 3 | Financials | 11.99% |
| 4 | Consumer Discretionary | 9.58% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Summit Therapeutics
SMMT
$10.5B
| $1.25M | ﹤0.01% |
301,699
-40,830
| -12% | -$162K |
|
3027
IQ MacKay Municipal Insured ETF
MMIN
$478M
| $1.25M | ﹤0.01% |
51,362
+605
| +1% | +$14.8K |
|
3028
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$2.97B
| $1.25M | ﹤0.01% |
40,400
-4,307
| -10% | -$132K |
|
3029
SkinHealth Systems
SKIN
$87.8M
| $1.24M | ﹤0.01% |
278,779
+2,182
| +0.8% | +$7.09K |
|
3030
Ooma
OOMA
$569M
| $1.24M | ﹤0.01% |
144,982
-1,989
| -1% | -$19.8K |
|
3031
OptimizeRx
OPRX
$167M
| $1.24M | ﹤0.01% |
101,678
-4,630
| -4% | -$67.1K |
|
|
CTLP
3032
DELISTED
Cantaloupe
CTLP
| $1.23M | ﹤0.01% |
192,056
-1,322
| -0.7% | -$8.72K |
|
|
SLRN
3033
DELISTED
ACELYRIN
SLRN
| $1.23M | ﹤0.01% |
182,337
+86,627
| +91% | +$658K |
|
3034
GoodRx Holdings
GDRX
$1.26B
| $1.23M | ﹤0.01% |
172,574
-33,069
| -16% | -$219K |
|
3035
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
$3.05B
| $1.22M | ﹤0.01% |
22,382
-3,568
| -14% | -$191K |
|
3036
MBIA
MBI
$259M
| $1.22M | ﹤0.01% |
180,694
-27,320
| -13% | -$173K |
|
3037
Wave Life Sciences
WVE
$1.04B
| $1.22M | ﹤0.01% |
197,878
+17,460
| +10% | +$87.4K |
|
3038
Anavex Life Sciences
AVXL
$294M
| $1.22M | ﹤0.01% |
239,661
-16,437
| -6% | -$92.5K |
|
3039
Teekay
TK
$1.08B
| $1.22M | ﹤0.01% |
167,428
+1,979
| +1% | +$15.5K |
|
3040
Stoke Therapeutics
STOK
$2B
| $1.21M | ﹤0.01% |
89,904
-8,424
| -9% | -$51K |
|
3041
Xponential Fitness
XPOF
$210M
| $1.21M | ﹤0.01% |
73,340
-12,233
| -14% | -$150K |
|
|
VRN
3042
DELISTED
Veren
VRN
| $1.21M | ﹤0.01% |
148,105
-44,669
| -23% | -$313K |
|
3043
Byrna Technologies
BYRN
$95.1M
| $1.21M | ﹤0.01% |
+86,869
| New | +$841K |
|
|
TELL
3044
DELISTED
Tellurian Inc.
TELL
| $1.21M | ﹤0.01% |
1,827,900
-145,100
| -7% | -$98.4K |
|
3045
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
| $1.21M | ﹤0.01% |
10,937
+3,507
| +47% | +$387K |
|
3046
WisdomTree International Quality Dividend Growth Fund
IQDG
$732M
| $1.21M | ﹤0.01% |
31,726
+326
| +1% | +$12K |
|
3047
Forrester Research
FORR
$223M
| $1.21M | ﹤0.01% |
55,942
-47,674
| -46% | -$1.08M |
|
3048
Microvision
MVIS
$50.9M
| $1.2M | ﹤0.01% |
43,622
-4,637
| -10% | -$158K |
|
3049
NextDecade
NEXT
$1.87B
| $1.2M | ﹤0.01% |
211,697
-17,470
| -8% | -$87.2K |
|
3050
Legacy Housing
LEGH
$698M
| $1.19M | ﹤0.01% |
55,230
+1,253
| +2% | +$30.1K |
|
Similar funds
Bank of New York Mellon's Q1 2024 Portfolio in Review
As of Q1 2024, Bank of New York Mellon held 4,422 positions worth $521B, up 5.6% from $493B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Bank of New York Mellon withdrew a net $17.6B in Q1 2024, closing 270 positions and reducing 3,087 holdings. Its most notable exit was Splunk Inc, an estimated $143M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Bank of New York Mellon opened a new position in Vanguard International Dividend Appreciation ETF worth $127M.
- Bank of New York Mellon's largest Q1 2024 buy was Vanguard International Dividend Appreciation ETF: 1,562,136 shares worth $127M.
- Bank of New York Mellon added most to ResMed in Q1 2024, an estimated $487M increase.
- Bank of New York Mellon's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $928M.
- Bank of New York Mellon fully exited Splunk Inc in Q1 2024, selling an estimated $143M.
- Bank of New York Mellon's ten largest holdings make up 22% of its $521B portfolio in Q1 2024.
- Bank of New York Mellon opened 113 new positions and closed 270 in Q1 2024.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $521B.
Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.